Evidence map›Paper›PMID 33284649›Full record

ArticleCirculation2020

"Sensing Danger": A New Player in the Innate Immune Response During Cardiac Pressure Overload.

Andrew N Carley, E Douglas Lewandowski

Abstract readEditorialComment
In one paragraph

Article in Circulation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Andrew N CarleyDavis Heart and Lung Research Institute and Department of Internal Medicine, The Ohio State University College of Medicine, Columbus.
E Douglas LewandowskiDavis Heart and Lung Research Institute and Department of Internal Medicine, The Ohio State University College of Medicine, Columbus.

Funding

Magnetic Resonance of Cardiac C13 Flux & Metabolism RateR01HL049244 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LEWANDOWSKI, E DOUGLAS · 1993 to 2018
$3.7M
Maladaptive Expression of Metabolic Enzymes and Activity in Heart FailureR01HL132525 · NHLBI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI LEWANDOWSKI, E DOUGLAS · 2016 to 2019
$2.5M
NHLBI NIH HHS R01 HL049244NHLBI NIH HHS R01 HL132525
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CardiomegalyMyocytes, CardiacHumansImmunity, InnateEditorialshypertrophy

Identifiers

PMID33284649
PMCPMC7727303

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.